ALPHA | Overview of Technology◾️What is Cabaletta Bio's SciTech?CAR-T transplanted from cancer treatment to autoimmune diseasesCabaletta Bio's core technology is the application of CAR-T cell therapy ...
Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.
Cancer is the second leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives them to ...
In cancer, tumor escape often arises following treatments. This is especially true during deprivation therapies, where this phenomenon has been linked to steroid signaling reactivation despite ...
The authors highlight three potential regulators - galectin 1, galectin 3, and Myc - providing solid evidence for potential roles in modulating the proliferation of cochlear GER cells using gene ...
Unphosphorylated Tyrosines Block T-Cell Signaling Condensate Formation / Anti-PD-1, anti-PD-L1, biomolecular condensates, ...
Cancer biology and, in turn, cancer treatment have come a long way in the last few decades. Most people recognize this ...
Elimination of PGE2 synthesis in immunotherapy-resistant melanoma cells restored their responsiveness to anti-PD1 treatment.
Scientists from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and St. Jude Children's ...
Oura Inc. publicly filed its Form S-1 registration statement with the U.S. Securities and Exchange Commission on September 3, 2026, revealing for the first time the financial details behind one of the ...